ABIVAX

Contact
abivax.com
+33 1 53 83 09 63
startup-iconStart-up

ABIVAX

7-11 Boulevard Haussmann
75009 Paris
France
+33 1 53 83 09 63
abivax.com
Contact
Profile News
Contact

About ABIVAX

ABIVAX is a leading clinical stage biotech company focused on becoming a global leader in the discovery, development and commercialisation of anti-viral compounds and human vaccines to treat some of the world’s most important infectious diseases, including HIV/AIDS and Hepatitis B.

Read more about ABIVAX
Facts about ABIVAX
  • Founding: 2013
  • Focus : Manufacturer
  • Industry : Biotechnology

News about ABIVAX

ABIVAX

03-Feb-2015 | research and development

Treatment of the first HIV positive patient in ABIVAX’s Phase IIa clinical trial with ABX464

ABIVAX announced that enrolment has been initiated and the first HIV positive patient dosed in a Phase IIa clinical trial of ABX464. ABX464 is a novel, ...

Read news
ABIVAX

03-Dec-2014 | research and development

ABIVAX successfully completes first-in-man study of ABX464, a highly differentiated small molecule targeting HIV

ABIVAX announced the successful completion of its Phase 1 first-in-man study of ABX464, which has been designed to potentially deliver a number of ...

Read news
Show more news about ABIVAX

Here you will find ABIVAX